FWAFX
Price
$42.76
Change
+$0.47 (+1.11%)
Updated
Jun 2 closing price
Net Assets
4B
RNPCX
Price
$73.05
Change
+$0.08 (+0.11%)
Updated
Jun 2 closing price
Net Assets
164.3B
Interact to see
Advertisement

FWAFX vs RNPCX

Header iconFWAFX vs RNPCX Comparison
Open Charts FWAFX vs RNPCXBanner chart's image
FWAFX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
FWAFX vs. RNPCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FWAFX is a Buy and RNPCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 164B vs. FWAFX (4B). RNPCX pays higher dividends than FWAFX: RNPCX (0.70) vs FWAFX (0.29). FWAFX was incepted earlier than RNPCX: FWAFX (17 years) vs RNPCX (24 years). FWAFX (1.06) and RNPCX (1.05) have similar cost to investors . FWAFX is a more actively managed with annual turnover of: 144.00 vs. RNPCX (23.00). FWAFX has a lower initial minimum investment than RNPCX: FWAFX (0) vs RNPCX (250). FWAFX annual gain was more profitable for investors over the last year : 25.95 vs. RNPCX (13.40). FWAFX (17.96) and RNPCX (17.30) have equivalent 5 years return.
FWAFXRNPCXFWAFX / RNPCX
Total Expense Ratio1.061.05101%
Annual Report Gross Expense Ratio1.061.05101%
Fund Existence17 years24 years-
Gain YTD19.3287.104272%
Front Load6%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets4B164B2%
Annual Yield % from dividends0.290.7042%
Returns for 1 year25.9513.40194%
Returns for 3 years53.7342.43127%
Returns for 5 years17.9617.30104%
Returns for 10 years97.30110.5088%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHB35.140.17
+0.49%
Bar Harbor Bankshares
DBRG15.67N/A
N/A
DigitalBridge Group
BWXT187.26-1.13
-0.60%
BWX Technologies
DH0.97-0.02
-1.68%
Definitive Healthcare Corp
ISPC3.07-0.27
-8.08%
iSpecimen Inc.